[ESPR] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
28-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- -20.85%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 78,447 227,547 148,364 184,474 0 0 0 -
PBT -269,108 -143,551 -97,165 -201,810 -166,988 -74,978 -49,784 32.44%
Tax 49,716 22,638 11,857 2,875 2,132 1,672 1,060 89.79%
NP -318,824 -166,189 -109,022 -201,810 -166,988 -74,978 -49,784 36.23%
Tax Rate - - - - - - - -
Total Cost 397,271 393,736 257,386 386,284 166,988 74,978 49,784 41.31%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -406.42 -73.04 -73.48 -109.40 0.00 0.00 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -11.03 -6.05 -4.02 -7.54 -6.98 -3.33 -2.26 30.20%
EPS Diluted -11.03 -6.05 -4.02 -7.54 -6.98 -3.33 -2.26 30.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.